Sp0982 021 — Peoria, Illinois

Sp0982 021 is a clinical research site located in Peoria, Illinois, United States 61637.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Sp0982 021 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB BIOSCIENCES, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Peoria

Browse all research sites in Illinois · View every site in Peoria

• Bradley University
• University of Illinois at Peoria
• University of Illinois College of Medicine
• St. Francis Hospital
• University of Illinois School of Medicine
• Children's Hospital of Illinois at OSF-Saint Francis Medical Center
• University of Illinois College of Medicine at Peoria
• University of Illinois College of Medicine at Peoria Pediatric Subspecialty Clinic
• Carle Health Methodist Hospital
• Saint Francis Medical Center/ Children's Hospital of Illinois/OSF
• St. Jude Children's Research Hospital
• Children's Hospital of Illinois at OSF Saint Francis Medical Center, Cystic Fibrosis Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sp0982 021?

Sp0982 021 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sp0982 021 conducted?

Sp0982 021 has 1 clinical trials on record. Their work covers Epilepsy.

Is Sp0982 021 accredited by Crixeo Clinical Trials?

Sp0982 021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sp0982 021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.